scispace - formally typeset
H

H. R. Withers

Researcher at University of California, Los Angeles

Publications -  24
Citations -  2566

H. R. Withers is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Linear model & Late effect. The author has an hindex of 14, co-authored 24 publications receiving 2497 citations. Previous affiliations of H. R. Withers include Oklahoma State University Center for Health Sciences.

Papers
More filters
Journal ArticleDOI

The hazard of accelerated tumor clonogen repopulation during radiotherapy.

TL;DR: It is suggested that, on average, clonogen repopulation in squamous cell carcinomas of the head and neck accelerates only after a lag period of the order of 4 +/- 1 weeks after initiation of radiotherapy and that a dose increment of about 0.6 Gy per day is required to compensate for this repopulating.
Journal ArticleDOI

Radiation survival and regeneration characteristics of spermatogenic stem cells of mouse testis.

TL;DR: Although surviving stem cells progress through the division cycle, and eventually form a focus of spermatogenesis, regeneration of stem cell numbers was not found in experiments, and the relevance of these characteristics to the development of fractionated-dose radiotherapy is discussed.
Journal ArticleDOI

Delayed molecular responses to brain irradiation

TL;DR: The data suggest that TNF-alpha may be involved in late brain responses to irradiation and could contribute to clinical symptoms after higher doses.
Journal ArticleDOI

Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation.

TL;DR: The dose-time factors in the external beam treatment of 473 patients with squamous cell carcinoma of the pharyngeal wall, vocal cord, pyriform sinus or supraglottic larynx were considered and estimates are consistent with accelerated tumor clonogen repopulation during irradiation.
Journal ArticleDOI

Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx

TL;DR: A strong correlation between the risk of late effect in the larynx and size of dose per fraction was found and there was no influence of overall treatment time.